Valsartan: Exporting France's Success
Executive SummaryNovartis' newfound marketing muscle has turned hypertension drug valsartan (Diovan) into a class leader worldwide, with $1.1 billion in sales last year. But the company's experience in France in tailoring its message to individual physicians has proved particularly successful, and provided a model for other countries.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.